235 related articles for article (PubMed ID: 20704554)
1. Disentangling the role of the tau gene locus in sporadic tauopathies.
Vandrovcova J; Anaya F; Kay V; Lees A; Hardy J; de Silva R
Curr Alzheimer Res; 2010 Dec; 7(8):726-34. PubMed ID: 20704554
[TBL] [Abstract][Full Text] [Related]
2. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
3. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
4. Untangling the tau gene association with neurodegenerative disorders.
Pittman AM; Fung HC; de Silva R
Hum Mol Genet; 2006 Oct; 15 Spec No 2():R188-95. PubMed ID: 16987883
[TBL] [Abstract][Full Text] [Related]
5. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
6. Mutations causing neurodegenerative tauopathies.
Goedert M; Jakes R
Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
[TBL] [Abstract][Full Text] [Related]
7. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
8. Genetic and sporadic forms of tauopathies-TAU as a disease driver for the majority of patients but the minority of tauopathies.
Zempel H
Cytoskeleton (Hoboken); 2024 Jan; 81(1):66-70. PubMed ID: 37795931
[TBL] [Abstract][Full Text] [Related]
9. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
10. Tau alternative splicing in familial and sporadic tauopathies.
Niblock M; Gallo JM
Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
[TBL] [Abstract][Full Text] [Related]
11. Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
Langerscheidt F; Wied T; Al Kabbani MA; van Eimeren T; Wunderlich G; Zempel H
J Neurol; 2024 Jun; 271(6):2992-3018. PubMed ID: 38554150
[TBL] [Abstract][Full Text] [Related]
12. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.
Valentino RR; Koga S; Walton RL; Soto-Beasley AI; Kouri N; DeTure MA; Murray ME; Johnson PW; Petersen RC; Boeve BF; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
Acta Neuropathol Commun; 2020 Dec; 8(1):218. PubMed ID: 33287913
[TBL] [Abstract][Full Text] [Related]
13. Tau and MAPT genetics in tauopathies and synucleinopathies.
Leveille E; Ross OA; Gan-Or Z
Parkinsonism Relat Disord; 2021 Sep; 90():142-154. PubMed ID: 34593302
[TBL] [Abstract][Full Text] [Related]
14. Genetic Architecture of Primary Tauopathies.
Gallo D; Ruiz A; Sánchez-Juan P
Neuroscience; 2023 May; 518():27-37. PubMed ID: 35609758
[TBL] [Abstract][Full Text] [Related]
15. Studying tauopathies in Drosophila: A fruitful model.
Sun M; Chen L
Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
[TBL] [Abstract][Full Text] [Related]
16. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
Rademakers R; Cruts M; van Broeckhoven C
Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
[TBL] [Abstract][Full Text] [Related]
17. Neurodegenerative tauopathies.
Lee VM; Goedert M; Trojanowski JQ
Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
[TBL] [Abstract][Full Text] [Related]
18. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
20. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
